BIOENVISION AS
Keywords
productionphotographic platesfilmphotosensitive paperchemical preparationsphotographicgelatingelatin derivativespeptonespeptone derivativessoft solderingbrazingactivated carbonlubricating oil additivesrubber acceleratorscatalystschemical productsanti-knock agentsantifreezehydrauliclaboratory reagentsinksmarkers
Organization
- CEO
- ES
Espen Solberg1968
- Chairman of the board
- ÅB
- Years since formation
- 3 years
- since Jun 9, 2021
- Type
- Limited company
- VAT registered
- Yes
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 423,116
- 1 share class
- Total number of shareholders
- 18
- 13 companies, 5 persons
- Belongs to group of
Financials
- Total operating income 2023
- 3,530,584
- NOK
- Annual total result 2023
- -26,052,807
- NOK
- Total equity 2023
- 24,479,106
- NOK
Last update: Aug 29, 2024
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
ES 1968 | Managing Director/CEO | - |
Board
| Name | Role | Shares |
|---|---|---|
EW 1975 | Board Member | - |
MA 1963 | Board Member | - |
RS 1956 | Board Member | - |
JA | Alternate Member | - |
JR 1968 | Observer | - |
PS 1967 | Observer | - |
TB 1962 | Board Member | - |
| Board Member | - | |
ÅB | Chairman | - |
Others
| Name | Role | Shares |
|---|---|---|
| Auditor | - | |
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
MF | - | 11.07 % indirectly |
ØN | - | 4 % indirectly |
LJ 1966 | - | 2.14 % indirectly |
Last update: Apr 29, 2024
Ownership
Company shareholders
| Name | Share class | Number of shares | Share |
|---|---|---|---|
| Ordinary shares | 165,913 | 39.21 % | |
| Ordinary shares | 58,638 | 13.86 % | |
| Ordinary shares | 55,918 | 13.22 % | |
| Ordinary shares | 43,710 | 10.33 % | |
| Ordinary shares | 42,779 | 10.11 % | |
| Ordinary shares | 31,889 | 7.54 % | |
| Ordinary shares | 13,333 | 3.15 % | |
| Ordinary shares | 6,666 | 1.58 % | |
| Ordinary shares | 2,105 | 0.5 % | |
| Ordinary shares | 793 | 0.19 % | |
| Ordinary shares | 539 | 0.13 % | |
| Ordinary shares | 214 | 0.05 % | |
| Ordinary shares | 214 | 0.05 % | |
MR | Ordinary shares | 130 | 0.03 % |
DH 1950 | Ordinary shares | 101 | 0.02 % |
TH 1982 | Ordinary shares | 88 | 0.02 % |
EL 1985 | Ordinary shares | 81 | 0.02 % |
SS 1984 | Ordinary shares | 5 | < 0.01 % |
Shares owned by the BIOENVISION AS
| Name | Share class | Number of shares | Share |
|---|---|---|---|
| NO0010830318 | 77,083,331 | 81.97 % |
Last update: May 24, 2024
Group structure
- Total operating income 2023: NOK 3,530,584Operating profit 2023: NOK -471,979Employees: 0
Financials
in NOK
Summary
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 3,530,584 | 810,177 | 220,763 |
Annual Total Result | -26,052,807 | -62,992,455 | -772,819 |
Total assets | 25,133,484 | 33,756,181 | 83,943,628 |
Total liabilities | 654,378 | 723,831 | 717,947 |
Total equity | 24,479,106 | 33,032,350 | 83,225,681 |
P&L
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total operating income | 3,530,584 | 810,177 | 220,763 |
Total operating costs | 4,002,564 | 9,492,625 | 973,014 |
Operating result | -471,979 | -8,682,448 | -752,251 |
Financial income/costs | -25,580,828 | -54,310,007 | -20,568 |
Profit before tax | -26,052,807 | -62,992,455 | -772,819 |
Total tax & extraordinary income/cost | 0 | 0 | 0 |
Annual Total Result | -26,052,807 | -62,992,455 | -772,819 |
Balance overview
| Year | 2023 | 2022 | 2021 |
|---|---|---|---|
Total fixed assets | 22,420,549 | 33,433,023 | 83,103,862 |
Total current assets | 2,712,935 | 323,158 | 839,766 |
Total assets | 25,133,484 | 33,756,181 | 83,943,628 |
Short term debt | 654,378 | 723,831 | 717,947 |
Long term debt | 0 | 0 | 0 |
Total liabilities | 654,378 | 723,831 | 717,947 |
Contributed capital | 24,479,106 | 96,797,625 | 83,998,500 |
Retained earnings | 0 | -63,765,275 | -772,819 |
Total equity | 24,479,106 | 33,032,350 | 83,225,681 |
Total equity and liabilities | 25,133,484 | 33,756,181 | 83,943,628 |
Classification
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
1120
Public incorporated enterprises, owned by central government
Standard industrial classification
C
Main industrial area
Manufacturing
20
Activity
Manufacture of chemicals and chemical products
20.5
Main industrial group
Manufacture of other chemical products
20.59
Industrial group
Manufacture of other chemical products n.e.c
20.590
Industrial group
Manufacture of other chemical products n.e.c